Search alternatives:
marked decrease » marked increase (Expand Search)
age decrease » a decrease (Expand Search), we decrease (Expand Search), rate decreased (Expand Search)
marked decrease » marked increase (Expand Search)
age decrease » a decrease (Expand Search), we decrease (Expand Search), rate decreased (Expand Search)
-
1
(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis.
Published 2025Subjects: -
2
-
3
-
4
-
5
Participants enrollment.
Published 2025“…Among the 422 caregivers who participated in the study, 267 (63.2%) were females and mean age was 44.94 years. The baseline mean knowledge level score was 9.5 (38.0%) and rose to 21.08 (84.3%) p = 0.000 immediate post-health education and a 2.1% decrease 20.54 (82.2%) p<0.001 at week six from the immediate post health education score. …”
-
6
KAP assessment scores (n = 422).
Published 2025“…Among the 422 caregivers who participated in the study, 267 (63.2%) were females and mean age was 44.94 years. The baseline mean knowledge level score was 9.5 (38.0%) and rose to 21.08 (84.3%) p = 0.000 immediate post-health education and a 2.1% decrease 20.54 (82.2%) p<0.001 at week six from the immediate post health education score. …”
-
7
Factors associated with AL score (multivariable regression analyses for the third follow-up).
Published 2025Subjects: -
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
Phylogenetic distance between partial pol-wgs mixtures and nFL genome for subset dataset.
Published 2025Subjects: -
16
Phylogenetic distance between partial pol-wgs mixtures and nFL genome for full dataset.
Published 2025Subjects: -
17
-
18
-
19
S1 File -
Published 2025“…Following the overexpression of miRNA 221 in myocardium, there was a marked alleviation of myocardial injury and cardiomyocyte apoptosis and necrosis, significant enhancement of left ventricular systolic function, and marked decrease in the levels of PLB, p-PLB (Ser16), p-PLB (Thr17), caspase 3 and Cyt C, as well as a significant decrease in total calcium levels in myocardium.…”
-
20
Annual treatment frequencies in all eyes.
Published 2025“…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”